Enbiosis
PrivateLast Round
VC Round
Jan 22, 2024
Company Overview
Enbiosis is a biotechnology company that provides AI-powered gut health solutions for personalized care and precision nutrition.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Vertical SaaS, Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enbiosis Comps
Public and private peers based on sector, stage, and business model.
Enbiosis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 22, 2024 | ||||
| Accelerator | May 1, 2023 | ||||
| Seed | May 27, 2021 |
Key People
Founding team and executive leadership
Enbiosis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QINVEST Portföy Yönetimi A.Ş. | VC Round |
| Grow London | Accelerator |
| Pragma Capital Partners | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2025
Grew 24% QoQ, from 21 to 26 employees.
- Jul 6, 2025
Monthly visitors increased 32% MoM.
Enbiosis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enbiosis's valuation, stock price, and market status.
